FOR CLINICAL TRIALS AND COMMERCIAL PRODUCTION
Using state-of-the-art single use bioreactors, LFB BIOMANUFACTURING can perform the GMP manufacturing of biopharmaceuticals for clinical trials and for commercial supply. Buffers and cell culture media are manufactured under GMP manufacturing conditions in dedicated bioproduction suites using the latest in single use technology.
LFB BIOMANUFACTURING has recently (2021) built a 3rd DSP workshop, dedicated to project requiring viral safety containment and notably used in the past years in the context of anti-COVID therapies
Currently, LFB BIOMANUFACTURING owns a wide range of disposable bioreactor platforms and cell culture systems including:
- Master and working GMP cell banking
- API Manufacturing of GMP batches 250L to 1,000L ; Additional capacities up to 6 times 2000L are being installed
- Quality Control and Stability studies
- CMC regulatory support